Evidence for a partially folded intermediate in alpha-synuclein fibril formation
- PMID: 11152691
- DOI: 10.1074/jbc.M010907200
Evidence for a partially folded intermediate in alpha-synuclein fibril formation
Abstract
Intracellular proteinaceous aggregates (Lewy bodies and Lewy neurites) of alpha-synuclein are hallmarks of neurodegenerative diseases such as Parkinson's disease, dementia with Lewy bodies, and multiple systemic atrophy. However, the molecular mechanisms underlying alpha-synuclein aggregation into such filamentous inclusions remain unknown. An intriguing aspect of this problem is that alpha-synuclein is a natively unfolded protein, with little or no ordered structure under physiological conditions. This raises the question of how an essentially disordered protein is transformed into highly organized fibrils. In the search for an answer to this question, we have investigated the effects of pH and temperature on the structural properties and fibrillation kinetics of human recombinant alpha-synuclein. Either a decrease in pH or an increase in temperature transformed alpha-synuclein into a partially folded conformation. The presence of this intermediate is strongly correlated with the enhanced formation of alpha-synuclein fibrils. We propose a model for the fibrillation of alpha-synuclein in which the first step is the conformational transformation of the natively unfolded protein into the aggregation-competent partially folded intermediate.
Similar articles
-
Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes.Biochemistry. 2003 Mar 11;42(9):2720-30. doi: 10.1021/bi027166s. Biochemistry. 2003. PMID: 12614167
-
Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.Biochemistry. 2001 Sep 25;40(38):11604-13. doi: 10.1021/bi010616g. Biochemistry. 2001. PMID: 11560511
-
Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.J Biol Chem. 2001 Nov 23;276(47):44284-96. doi: 10.1074/jbc.M105343200. Epub 2001 Sep 11. J Biol Chem. 2001. PMID: 11553618
-
Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle.FEBS Lett. 2002 Jul 3;522(1-3):9-13. doi: 10.1016/s0014-5793(02)02883-1. FEBS Lett. 2002. PMID: 12095610 Review.
-
Α-synuclein misfolding and Parkinson's disease.Biochim Biophys Acta. 2012 Feb;1822(2):261-85. doi: 10.1016/j.bbadis.2011.10.002. Epub 2011 Oct 12. Biochim Biophys Acta. 2012. PMID: 22024360 Review.
Cited by
-
A decade and a half of protein intrinsic disorder: biology still waits for physics.Protein Sci. 2013 Jun;22(6):693-724. doi: 10.1002/pro.2261. Epub 2013 Apr 29. Protein Sci. 2013. PMID: 23553817 Free PMC article. Review.
-
Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia.Oxid Med Cell Longev. 2022 Oct 6;2022:7165387. doi: 10.1155/2022/7165387. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36246407 Free PMC article. Review.
-
α-Synuclein Fibril, Ribbon and Fibril-91 Amyloid Polymorphs Generation for Structural Studies.Methods Mol Biol. 2023;2551:345-355. doi: 10.1007/978-1-0716-2597-2_23. Methods Mol Biol. 2023. PMID: 36310214
-
Protein structural conformation and not second virial coefficient relates to long-term irreversible aggregation of a monoclonal antibody and ovalbumin in solution.Pharm Res. 2006 Jun;23(6):1382-94. doi: 10.1007/s11095-006-0018-y. Epub 2006 May 25. Pharm Res. 2006. PMID: 16715374
-
Probing the Basis of α-Synuclein Aggregation by Comparing Simulations to Single-Molecule Experiments.Biophys J. 2019 Sep 17;117(6):1125-1135. doi: 10.1016/j.bpj.2019.08.013. Epub 2019 Aug 16. Biophys J. 2019. PMID: 31477241 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
